-
1
-
-
75749092296
-
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
-
19949017 10.1200/JCO.2009.23.1274 1:CAS:528:DC%2BC3cXivFartbk%3D
-
M Dowsett J Cuzick J Ingle A Coates J Forbes J Bliss M Buyse M Baum A Buzdar M Colleoni C Coombes C Snowdon M Gnant R Jakesz M Kaufmann F Boccardo J Godwin C Davies R Peto 2010 Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen J Clin Oncol 28 509 518 19949017 10.1200/JCO.2009.23.1274 1:CAS:528:DC%2BC3cXivFartbk%3D
-
(2010)
J Clin Oncol
, vol.28
, pp. 509-518
-
-
Dowsett, M.1
Cuzick, J.2
Ingle, J.3
Coates, A.4
Forbes, J.5
Bliss, J.6
Buyse, M.7
Baum, M.8
Buzdar, A.9
Colleoni, M.10
Coombes, C.11
Snowdon, C.12
Gnant, M.13
Jakesz, R.14
Kaufmann, M.15
Boccardo, F.16
Godwin, J.17
Davies, C.18
Peto, R.19
-
2
-
-
70349932822
-
Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
-
19189211 10.1007/s10549-008-0295-8
-
S Nofech-Mozes M Trudeau HK Kahn R Dent E Rawlinson P Sun SA Narod WM Hanna 2009 Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers Breast Cancer Res Treat 118 131 137 19189211 10.1007/s10549-008-0295-8
-
(2009)
Breast Cancer Res Treat
, vol.118
, pp. 131-137
-
-
Nofech-Mozes, S.1
Trudeau, M.2
Kahn, H.K.3
Dent, R.4
Rawlinson, E.5
Sun, P.6
Narod, S.A.7
Hanna, W.M.8
-
3
-
-
33847063053
-
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
-
17438091 10.1158/1078-0432.CCR-06-1109 1:CAS:528:DC%2BD2sXkt1enur0%3D
-
LA Carey EC Dees L Sawyer L Gatti DT Moore F Collichio DW Ollila CI Sartor ML Graham CM Perou 2007 The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res 13 2329 2334 17438091 10.1158/1078-0432.CCR-06-1109 1:CAS:528:DC%2BD2sXkt1enur0%3D
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2329-2334
-
-
Carey, L.A.1
Dees, E.C.2
Sawyer, L.3
Gatti, L.4
Moore, D.T.5
Collichio, F.6
Ollila, D.W.7
Sartor, C.I.8
Graham, M.L.9
Perou, C.M.10
-
4
-
-
77957599220
-
Poly(ADP-ribose) polymerase inhibition: "Targeted" therapy for triple-negative breast cancer
-
20858840 10.1158/1078-0432.CCR-10-0939 1:CAS:528:DC%2BC3cXht1aktbjM
-
CK Anders EP Winer JM Ford R Dent DP Silver GW Sledge LA Carey 2010 Poly(ADP-ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer Clin Cancer Res 16 4702 4710 20858840 10.1158/1078-0432.CCR-10-0939 1:CAS:528:DC%2BC3cXht1aktbjM
-
(2010)
Clin Cancer Res
, vol.16
, pp. 4702-4710
-
-
Anders, C.K.1
Winer, E.P.2
Ford, J.M.3
Dent, R.4
Silver, D.P.5
Sledge, G.W.6
Carey, L.A.7
-
5
-
-
79251541469
-
PARP inhibitors in breast cancer
-
21157412
-
ML Telli JM Ford 2010 PARP inhibitors in breast cancer Clin Adv Hematol Oncol 8 629 635 21157412
-
(2010)
Clin Adv Hematol Oncol
, vol.8
, pp. 629-635
-
-
Telli, M.L.1
Ford, J.M.2
-
6
-
-
0035576805
-
Akt activation by estrogen in estrogen receptor-negative breast cancer cells
-
11731414 1:CAS:528:DC%2BD3MXptFCktLw%3D
-
EM Tsai SC Wang JN Lee MC Hung 2001 Akt activation by estrogen in estrogen receptor-negative breast cancer cells Cancer Res 61 8390 8392 11731414 1:CAS:528:DC%2BD3MXptFCktLw%3D
-
(2001)
Cancer Res
, vol.61
, pp. 8390-8392
-
-
Tsai, E.M.1
Wang, S.C.2
Lee, J.N.3
Hung, M.C.4
-
7
-
-
0027964862
-
Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
-
8078914 10.1073/pnas.91.18.8517 1:CAS:528:DyaK2cXlslSrtr4%3D
-
SM Aronica WL Kraus BS Katzenellenbogen 1994 Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription Proc Natl Acad Sci USA 91 8517 8521 8078914 10.1073/pnas.91.18. 8517 1:CAS:528:DyaK2cXlslSrtr4%3D
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 8517-8521
-
-
Aronica, S.M.1
Kraus, W.L.2
Katzenellenbogen, B.S.3
-
8
-
-
0029669930
-
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
-
8635462 1:CAS:528:DyaK28XitFWjtLo%3D
-
A Migliaccio M Di Domenico G Castoria A de Falco P Bontempo E Nola F Auricchio 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells EMBO J 15 1292 1300 8635462 1:CAS:528:DyaK28XitFWjtLo%3D
-
(1996)
EMBO J
, vol.15
, pp. 1292-1300
-
-
Migliaccio, A.1
Di Domenico, M.2
Castoria, G.3
De Falco, A.4
Bontempo, P.5
Nola, E.6
Auricchio, F.7
-
9
-
-
33846951482
-
17Beta-estradiol and tamoxifen stimulate rapid and transient ERK activation in MCF-7 cells via distinct signaling mechanisms
-
17106250 10.4161/cbt.5.12.3378 1:CAS:528:DC%2BD2sXksVyqsrs%3D
-
H Visram PA Greer 2006 17Beta-estradiol and tamoxifen stimulate rapid and transient ERK activation in MCF-7 cells via distinct signaling mechanisms Cancer Biol Ther 5 1677 1682 17106250 10.4161/cbt.5.12.3378 1:CAS:528: DC%2BD2sXksVyqsrs%3D
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 1677-1682
-
-
Visram, H.1
Greer, P.A.2
-
10
-
-
0036139164
-
ERs associate with and regulate the production of caveolin: Implications for signaling and cellular actions
-
11773442 10.1210/me.16.1.100 1:CAS:528:DC%2BD38XhvVCiuw%3D%3D
-
M Razandi P Oh A Pedram J Schnitzer ER Levin 2002 ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions Mol Endocrinol 16 100 115 11773442 10.1210/me.16.1.100 1:CAS:528:DC%2BD38XhvVCiuw%3D%3D
-
(2002)
Mol Endocrinol
, vol.16
, pp. 100-115
-
-
Razandi, M.1
Oh, P.2
Pedram, A.3
Schnitzer, J.4
Levin, E.R.5
-
11
-
-
0033780783
-
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
-
11043579 10.1210/me.14.10.1649 1:CAS:528:DC%2BD3cXntVaksLk%3D
-
EJ Filardo JA Quinn KI Bland AR Frackelton Jr 2000 Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Mol Endocrinol 14 1649 1660 11043579 10.1210/me.14.10.1649 1:CAS:528:DC%2BD3cXntVaksLk%3D
-
(2000)
Mol Endocrinol
, vol.14
, pp. 1649-1660
-
-
Filardo, E.J.1
Quinn, J.A.2
Bland, K.I.3
Frackelton Jr., A.R.4
-
12
-
-
14844343093
-
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
-
15705806 10.1126/science.1106943 1:CAS:528:DC%2BD2MXitV2is7c%3D
-
CM Revankar DF Cimino LA Sklar JB Arterburn ER Prossnitz 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 307 1625 1630 15705806 10.1126/science.1106943 1:CAS:528: DC%2BD2MXitV2is7c%3D
-
(2005)
Science
, vol.307
, pp. 1625-1630
-
-
Revankar, C.M.1
Cimino, D.F.2
Sklar, L.A.3
Arterburn, J.B.4
Prossnitz, E.R.5
-
13
-
-
0032938716
-
Regulation of tyrosine kinase cascades by G-protein-coupled receptors
-
10209148 10.1016/S0955-0674(99)80023-4 1:CAS:528:DyaK1MXisFWlsLg%3D
-
LM Luttrell Y Daaka RJ Lefkowitz 1999 Regulation of tyrosine kinase cascades by G-protein-coupled receptors Curr Opin Cell Biol 11 177 183 10209148 10.1016/S0955-0674(99)80023-4 1:CAS:528:DyaK1MXisFWlsLg%3D
-
(1999)
Curr Opin Cell Biol
, vol.11
, pp. 177-183
-
-
Luttrell, L.M.1
Daaka, Y.2
Lefkowitz, R.J.3
-
14
-
-
3042547161
-
The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells
-
15090535 10.1074/jbc.M403588200 1:CAS:528:DC%2BD2cXkvFGnsrc%3D
-
M Maggiolini A Vivacqua G Fasanella AG Recchia D Sisci V Pezzi D Montanaro AM Musti D Picard S Ando 2004 The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells J Biol Chem 279 27008 27016 15090535 10.1074/jbc.M403588200 1:CAS:528:DC%2BD2cXkvFGnsrc%3D
-
(2004)
J Biol Chem
, vol.279
, pp. 27008-27016
-
-
Maggiolini, M.1
Vivacqua, A.2
Fasanella, G.3
Recchia, A.G.4
Sisci, D.5
Pezzi, V.6
Montanaro, D.7
Musti, A.M.8
Picard, D.9
Ando, S.10
-
15
-
-
70349169955
-
ERalpha-negative and triple negative breast cancer: Molecular features and potential therapeutic approaches
-
19527773 1:CAS:528:DC%2BD1MXhtFyqsLnM
-
JQ Chen J Russo 2009 ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches Biochim Biophys Acta 1796 162 175 19527773 1:CAS:528:DC%2BD1MXhtFyqsLnM
-
(2009)
Biochim Biophys Acta
, vol.1796
, pp. 162-175
-
-
Chen, J.Q.1
Russo, J.2
-
16
-
-
0346432140
-
Tracking the elusive antiestrogenic effect of melatonin: A new methodological approach
-
15073572 1:CAS:528:DC%2BD2cXotlCjsg%3D%3D
-
R Girgert C Bartsch SM Hill R Kreienberg V Hanf 2003 Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach Neuroendocrinol Lett 24 440 444 15073572 1:CAS:528:DC%2BD2cXotlCjsg%3D%3D
-
(2003)
Neuroendocrinol Lett
, vol.24
, pp. 440-444
-
-
Girgert, R.1
Bartsch, C.2
Hill, S.M.3
Kreienberg, R.4
Hanf, V.5
-
17
-
-
0017353576
-
Development of methods for the quantitative in vitro analysis of androgen-dependent and autonomous Shionogi carcinoma 115 cells
-
837442 10.1016/0092-8674(77)90137-4 1:CAS:528:DyaE2sXhtFOhsbY%3D
-
ER Stanley RE Palmer U Sohn 1977 Development of methods for the quantitative in vitro analysis of androgen-dependent and autonomous Shionogi carcinoma 115 cells Cell 10 35 44 837442 10.1016/0092-8674(77)90137-4 1:CAS:528:DyaE2sXhtFOhsbY%3D
-
(1977)
Cell
, vol.10
, pp. 35-44
-
-
Stanley, E.R.1
Palmer, R.E.2
Sohn, U.3
-
18
-
-
76249112330
-
Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-I receptor in breast cancer cells resistant to herceptin
-
20103628 10.1158/0008-5472.CAN-09-3321 1:CAS:528:DC%2BC3cXht12rurc%3D
-
X Huang L Gao S Wang JL McManaman AD Thor X Yang FJ Esteva B Liu 2010 Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-I receptor in breast cancer cells resistant to herceptin Cancer Res 70 1204 1214 20103628 10.1158/0008-5472.CAN-09-3321 1:CAS:528:DC%2BC3cXht12rurc%3D
-
(2010)
Cancer Res
, vol.70
, pp. 1204-1214
-
-
Huang, X.1
Gao, L.2
Wang, S.3
McManaman, J.L.4
Thor, A.D.5
Yang, X.6
Esteva, F.J.7
Liu, B.8
-
19
-
-
4143150688
-
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
-
15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D
-
TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu T Hernandez-Boussard C Livasy D Cowan L Dressler LA Akslen J Ragaz AM Gown CB Gilks M van de Rijn CM Perou 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5367-5374
-
-
Nielsen, T.O.1
Hsu, F.D.2
Jensen, K.3
Cheang, M.4
Karaca, G.5
Hu, Z.6
Hernandez-Boussard, T.7
Livasy, C.8
Cowan, D.9
Dressler, L.10
Akslen, L.A.11
Ragaz, J.12
Gown, A.M.13
Gilks, C.B.14
Van De Rijn, M.15
Perou, C.M.16
-
20
-
-
47949111993
-
Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells
-
18467441 10.1210/en.2008-0117 1:CAS:528:DC%2BD1cXptlamsLk%3D
-
L Albanito D Sisci S Aquila E Brunelli A Vivacqua A Madeo R Lappano DP Pandey D Picard L Mauro S Ando M Maggiolini 2008 Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells Endocrinology 149 3799 3808 18467441 10.1210/en.2008-0117 1:CAS:528:DC%2BD1cXptlamsLk%3D
-
(2008)
Endocrinology
, vol.149
, pp. 3799-3808
-
-
Albanito, L.1
Sisci, D.2
Aquila, S.3
Brunelli, E.4
Vivacqua, A.5
Madeo, A.6
Lappano, R.7
Pandey, D.P.8
Picard, D.9
Mauro, L.10
Ando, S.11
Maggiolini, M.12
-
21
-
-
77949568658
-
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells
-
20138962 10.1016/j.mce.2010.02.006 1:CAS:528:DC%2BC3cXjslSkt7s%3D
-
R Lappano C Rosano P De Marco EM De Francesco V Pezzi M Maggiolini 2010 Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells Mol Cell Endocrinol 320 162 170 20138962 10.1016/j.mce.2010.02.006 1:CAS:528:DC%2BC3cXjslSkt7s%3D
-
(2010)
Mol Cell Endocrinol
, vol.320
, pp. 162-170
-
-
Lappano, R.1
Rosano, C.2
De Marco, P.3
De Francesco, E.M.4
Pezzi, V.5
Maggiolini, M.6
-
22
-
-
67349140294
-
In vivo effects of a GPR30 antagonist
-
19430488 10.1038/nchembio.168 1:CAS:528:DC%2BD1MXls1Cmtr0%3D
-
MK Dennis R Burai C Ramesh WK Petrie SN Alcon TK Nayak CG Bologa A Leitao E Brailoiu E Deliu NJ Dun LA Sklar HJ Hathaway JB Arterburn TI Oprea ER Prossnitz 2009 In vivo effects of a GPR30 antagonist Nat Chem Biol 5 421 427 19430488 10.1038/nchembio.168 1:CAS:528:DC%2BD1MXls1Cmtr0%3D
-
(2009)
Nat Chem Biol
, vol.5
, pp. 421-427
-
-
Dennis, M.K.1
Burai, R.2
Ramesh, C.3
Petrie, W.K.4
Alcon, S.N.5
Nayak, T.K.6
Bologa, C.G.7
Leitao, A.8
Brailoiu, E.9
Deliu, E.10
Dun, N.J.11
Sklar, L.A.12
Hathaway, H.J.13
Arterburn, J.B.14
Oprea, T.I.15
Prossnitz, E.R.16
|